Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Causal relationship between the loss of RUNX3 expression and gastric cancer.

Li QL, Ito K, Sakakura C, Fukamachi H, Inoue Ki, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y.

Cell. 2002 Apr 5;109(1):113-24.

2.

RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.

Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC.

Mol Cell Biol. 2005 Sep;25(18):8097-107.

3.

Growth regulation of gastric epithelial cells by Runx3.

Fukamachi H, Ito K.

Oncogene. 2004 May 24;23(24):4330-5. Review.

PMID:
15156189
4.

Runx3-/- gastric epithelial cells differentiate into intestinal type cells.

Fukamachi H, Ito K, Ito Y.

Biochem Biophys Res Commun. 2004 Aug 13;321(1):58-64.

PMID:
15358215
5.

Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.

Sakakura C, Hasegawa K, Miyagawa K, Nakashima S, Yoshikawa T, Kin S, Nakase Y, Yazumi S, Yamagishi H, Okanoue T, Chiba T, Hagiwara A.

Clin Cancer Res. 2005 Sep 15;11(18):6479-88.

6.

RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization.

Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y.

Cancer Res. 2005 Sep 1;65(17):7743-50. Erratum in: Cancer Res. 2006 Mar 15;66(6):3345.

7.

Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor.

Guo WH, Weng LQ, Ito K, Chen LF, Nakanishi H, Tatematsu M, Ito Y.

Oncogene. 2002 Nov 28;21(54):8351-5.

8.

Tumor suppressor activity of RUNX3.

Bae SC, Choi JK.

Oncogene. 2004 May 24;23(24):4336-40. Review.

PMID:
15156190
9.

Runx3 controls growth and differentiation of gastric epithelial cells in mammals.

Fukamachi H.

Dev Growth Differ. 2006 Jan;48(1):1-13. Review.

PMID:
16466388
10.

Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia.

Waki T, Tamura G, Sato M, Terashima M, Nishizuka S, Motoyama T.

Cancer Sci. 2003 Apr;94(4):360-4.

11.

Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.

Wada M, Yazumi S, Takaishi S, Hasegawa K, Sawada M, Tanaka H, Ida H, Sakakura C, Ito K, Ito Y, Chiba T.

Oncogene. 2004 Mar 25;23(13):2401-7.

PMID:
14743205
12.

GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling.

Saeki N, Kim DH, Usui T, Aoyagi K, Tatsuta T, Aoki K, Yanagihara K, Tamura M, Mizushima H, Sakamoto H, Ogawa K, Ohki M, Shiroishi T, Yoshida T, Sasaki H.

Oncogene. 2007 Oct 4;26(45):6488-98.

PMID:
17471240
13.

RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells.

Torquati A, O'rear L, Longobardi L, Spagnoli A, Richards WO, Daniel Beauchamp R.

Surgery. 2004 Aug;136(2):310-6.

PMID:
15300196
14.

RUNX: a trilogy of cancer genes.

Lund AH, van Lohuizen M.

Cancer Cell. 2002 Apr;1(3):213-5. Review.

15.

[Relationship between Runx3 gene expression and its DNA methylation in gastric cancer].

Gao N, Chen WC, Cen JN.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):361-4. Chinese.

PMID:
18953836
16.

Tumor suppressor, AT motif binding factor 1 (ATBF1), translocates to the nucleus with runt domain transcription factor 3 (RUNX3) in response to TGF-beta signal transduction.

Mabuchi M, Kataoka H, Miura Y, Kim TS, Kawaguchi M, Ebi M, Tanaka M, Mori Y, Kubota E, Mizushima T, Shimura T, Mizoshita T, Tanida S, Kamiya T, Asai K, Joh T.

Biochem Biophys Res Commun. 2010 Jul 23;398(2):321-5. doi: 10.1016/j.bbrc.2010.06.090.

PMID:
20599712
17.

Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines.

Yanada M, Yaoi T, Shimada J, Sakakura C, Nishimura M, Ito K, Terauchi K, Nishiyama K, Itoh K, Fushiki S.

Oncol Rep. 2005 Oct;14(4):817-22.

PMID:
16142337
18.

Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia.

Brenner O, Levanon D, Negreanu V, Golubkov O, Fainaru O, Woolf E, Groner Y.

Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):16016-21.

19.

Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines.

Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ, Shin JH, Han IO, Park JG.

Oncogene. 2004 Sep 2;23(40):6736-42.

PMID:
15273736
20.

Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.

Hsu PI, Hsieh HL, Lee J, Lin LF, Chen HC, Lu PJ, Hsiao M.

Ann Surg Oncol. 2009 Jun;16(6):1686-94. doi: 10.1245/s10434-009-0428-2.

PMID:
19290488
Items per page

Supplemental Content

Support Center